Richard S. Tedder

SARS-CoV-2 antibody responses associate with sex, age and disease severity in previously uninfected people admitted to hospital with COVID-19: An ISARIC4C prospective study

Delayed Mucosal Antiviral Responses Despite Robust Peripheral Inflammation in Fatal COVID-19

National and regional prevalence of SARS-CoV-2 antibodies in primary and secondary school children in England: the School Infection Survey, a national open cohort study, November 2021SARS-CoV-2 antibody prevalence in school children

Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts

Plasmodium infection is associated with cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study

Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19

Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study

SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity

Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK

Ebola virus antibody decay–stimulation in a high proportion of survivors

Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England

Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England

Cost-Effectiveness Analysis of Screening for Persistent Hepatitis E Virus Infection in Solid Organ Transplant Patients in the United Kingdom: A Model-Based Economic Evaluation

Characterising the risk of Hepatitis E virus infection in haematological malignancies: a <scp>UK</scp> prospective prevalence study

Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone

Antibody-based assay discriminates Zika virus infection from other flaviviruses

Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive assay for antibodies to Ebola virus

Ebola exposure, illness experience, and Ebola antibody prevalence in international responders to the West African Ebola epidemic 2014–2016: A cross-sectional study

Therapy‐induced clearance of HCV core antigen from plasma predicts an end of treatment viral response